Health Care — FDA halts authorization of last COVID antibody drug

RIP to Christine McVie, the singer-songwriter responsible for some of Fleetwood Mac’s biggest hits.   Today in health, the rise of new COVID-19 omicron subvariants BQ.1 and BQ.1.1 has led to the one remaining monoclonal antibody treatment no longer being authorized by the FDA.  Welcome to Overnight Health Care, where we’re following the latest moves on… Continue reading Health Care — FDA halts authorization of last COVID antibody drug

Alzheimer's drug lecanemab hailed as momentous breakthrough

One of the world’s leading researchers behind the whole idea of targeting amyloid 30 years ago, Prof John Hardy, said it was “historic” and was optimistic “we’re seeing the beginning of Alzheimer’s therapies”. Prof Tara Spires-Jones, from the University of Edinburgh, said the results were “a big deal because we’ve had a 100% failure rate… Continue reading Alzheimer's drug lecanemab hailed as momentous breakthrough

Game-changing type 1 diabetes drug approved in US

It is the first drug to be approved that delays the onset of the condition. Source link

New York reaches $523 million opioid settlement with drug manufacturer Teva

New York state has reached a $523 million settlement with drug manufacturer Teva Pharmaceuticals, closing out the state’s massive legal battle against opioid manufacturers and distributors, New York Attorney General Letitia James (D) announced on Thursday. “We are holding Teva Pharmaceuticals accountable for its role in the opioid crisis and the irreparable harm it has done to… Continue reading New York reaches $523 million opioid settlement with drug manufacturer Teva

Democrats try to break through on drug pricing message

Much of the public appears to be largely in the dark about Democrats’ signature effort to let Medicare negotiate drug prices, a potentially troubling sign ahead of next month’s midterm elections.  The inclusion of a provision allowing those negotiations in the Inflation Reduction Act marked the culmination of an at least 20-year push by Democrats… Continue reading Democrats try to break through on drug pricing message

Health Care — Biden pushes drug price wins

Welcome to Tuesday’s Overnight Health Care, where we’re following the latest moves on policy and news affecting your health. Subscribe here  Shutdown watch: the government spending bill appears to be on track to pass later this week, and lawmakers are ready to hit the campaign trail ahead of the mid-term elections.  Today in health, President… Continue reading Health Care — Biden pushes drug price wins

Rise in teenage vaping, as drug use falls – survey

Among 11-15-year-olds in England, 9% say they use e-cigarettes – up from 6% in 2018, a survey suggests. Source link

How New Federal Legislation Might Cut Your Drug Costs

By Steven Reinberg HealthDay ReporterHealthDay Reporter FRIDAY, Aug. 12, 2022 (HealthDay News) — The Inflation Reduction Act is expected to bring out-of-pocket drug costs down for many U.S. seniors, but most of its benefits aren’t immediate. Under the law, Medicare will now be allowed to negotiate the cost of some drugs. That should eventually bring… Continue reading How New Federal Legislation Might Cut Your Drug Costs

Remission seen in every rectal cancer patient in small study of drug

A new drug called dostarlimab saw astonishing results in a 12-person rectal cancer trial: Every one of the dozen patients went into remission. All the patients were still in remission in a six-month follow-up of the trial as well. Additionally, none of the patients had received chemoradiotherapy or undergone any preventative surgery, and no cases… Continue reading Remission seen in every rectal cancer patient in small study of drug

Drug Could Be Non-Antibiotic Alternative to Treat UTIs

FRIDAY, March 11, 2022 (HealthDay News) — Women plagued by frequent urinary tract infections often take daily antibiotics to ward them off. But an old antibiotic alternative might work just as well, a new clinical trial finds. Researchers found that the medication, called methenamine, was comparable to standard, low-dose antibiotics in preventing women’s recurrent urinary… Continue reading Drug Could Be Non-Antibiotic Alternative to Treat UTIs